Overview

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

Status:
Unknown status
Trial end date:
2006-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the project is to shown whether a little dose of a short acting insulin analogue given 3 time daily before the meals compared with placebo could normalise the increase in blood glucose after teh meals in diet treated Type 2 diabetic patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Treatments:
Insulin
Insulin Aspart
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

Type 2 diabtes according to the WHO criteria Fasting blood glucose >7 HbA1c between 6-9
Normal liver function Normal renal function

-

Exclusion Criteria:

Ongoing treatment with antidiabetic medicine Pregnancy and lactation -